SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: BigKNY3 who wrote (19882)3/19/1999 9:07:00 AM
From: VLAD  Respond to of 23519
 
MUSE scripts for week ending 3/2:

New 1,809
Refill 1,561

NO SALES FORCE FOR NINE MONTHS NOW!!!!!

VLAD

PS Shoo fly don't bother me!



To: BigKNY3 who wrote (19882)3/19/1999 9:21:00 AM
From: VLAD  Respond to of 23519
 
PSS

You get a "real" sales force detailing MUSE to the PCPs and I guarantee you will see script levels higher than the 1997 preViagra weekly average of 15,800.

Assume that out of all the PCPs only 1/2 end up knowing about it and out of that 1/2 they write only one prescription a month. This would give us a total weekly script count of over 30,000.

OK, let's say I'm too optimistic and out of the 1/2 that know about it only 1/2 write a script once a month which would give us a weekly script count over 15,000. Add scripts written by specialists and we will easily break the 1997 preViagra average.

VLAD

PS Someone will take on MUSE soon especially if Vivus throws in the Oris Ointment as an "extra" since this is where some real serious money will be made soon enough!